New Age Alpha Advisors, LLC Collegium Pharmaceutical, Inc Transaction History
New Age Alpha Advisors, LLC
- $2.47 Trillion
- Q4 2024
A detailed history of New Age Alpha Advisors, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 1,383 shares of COLL stock, worth $43,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,383Holding current value
$43,675% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
37MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$183 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$83.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$72.1 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$67.7 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$52.3 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.08B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...